Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism (SHPT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01219855
What this trial is testing

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismVitamin D Insufficiency
OPKO Health, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT02133404
What this trial is testing

Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Astellas Pharma Inc 62
Not applicableStudy completedNCT01265992
What this trial is testing

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
AbbVie (prior sponsor, Abbott) 50
Testing effectiveness (Phase 2)Ended earlyNCT03602261
What this trial is testing

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesChronic Kidney DiseasesVitamin D Deficiency+1 more
OPKO Health, Inc. 44
Not applicableStudy completedNCT01149291
What this trial is testing

Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
AbbVie (prior sponsor, Abbott) 511
Post-approval studies (Phase 4)Study completedNCT00123461
What this trial is testing

Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismRenal FailureChronic Renal Insufficiency
Genzyme, a Sanofi Company 70
Not applicableStudy completedNCT05460234
What this trial is testing

RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients

Who this might be right for
Chronic Kidney Disease
Vifor (International) Inc. 110
Not applicableUnknownNCT04523974
What this trial is testing

Preemptive and Precise Intervention for CKD-SHPT

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Shanghai Zhongshan Hospital 50
Large-scale testing (Phase 3)Study completedNCT01896232
What this trial is testing

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 683
Early research (Phase 1)Study completedNCT02833857
What this trial is testing

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

Who this might be right for
Chronic Kidney Disease, Secondary Hyperparathyroidism
Amgen 11
Large-scale testing (Phase 3)Ended earlyNCT04064827
What this trial is testing

Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)
AbbVie 2
Post-approval studies (Phase 4)Study completedNCT00977080
What this trial is testing

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismHemodialysis
Abbott 272
Post-approval studies (Phase 4)Study completedNCT00431496
What this trial is testing

Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)

Who this might be right for
AnemiaSecondary Hyperparathyroidism
Amgen 71
Not applicableStudy completedNCT01224782
What this trial is testing

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 994
Testing effectiveness (Phase 2)Study completedNCT00113958
What this trial is testing

Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels

Who this might be right for
End Stage Renal Disease
Amgen
Large-scale testing (Phase 3)Ended earlyNCT02138838
What this trial is testing

Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis

Who this might be right for
Chronic Kidney Disease, Secondary Hyperparathyroidism
Amgen 55
Testing effectiveness (Phase 2)Study completedNCT06747247
What this trial is testing

A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 98
Not applicableStudy completedNCT01083849
What this trial is testing

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

Who this might be right for
Kidney InsufficiencySecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 761
Early research (Phase 1)Study completedNCT00792857
What this trial is testing

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 24
Not applicableUnknownNCT05549154
What this trial is testing

A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation

Who this might be right for
Chronic Kidney Disease 5DSecondary Hyperparathyroidism Due to Renal CausesVitamin D Deficiency
First Affiliated Hospital Xi'an Jiaotong University 372
Next Page